News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
137 Results
Type
Article (4)
Press Release (133)
Section
Business (20)
Deals (1)
Drug Development (4)
News (32)
Policy (8)
Tag
Alliances (8)
Cancer (4)
Clinical research (4)
Data (2)
Earnings (2)
Events (21)
Intellectual property (2)
IPO (1)
Legal (3)
Pancreatic cancer (2)
Patents (4)
People (11)
Phase 1 (4)
Pipeline (4)
Preclinical (1)
Regulatory (6)
Date
Last 7 days (1)
Last 30 days (4)
Last 365 days (11)
2026 (4)
2025 (7)
2024 (5)
2023 (14)
2022 (29)
2021 (9)
2020 (11)
2019 (16)
2018 (12)
2017 (12)
2016 (16)
2015 (1)
2014 (1)
Location
Asia (19)
Australia (133)
Europe (1)
137 Results for "propanc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Propanc Biopharma Explains How PRP Could Impact Pancreatic Cancer
January 16, 2026
·
6 min read
Press Releases
Propanc Biopharma Files New Provisional Patent Application for Methods of Producing Trypsinogen & Chymotrypsinogen with IP Australia
January 20, 2026
·
4 min read
Press Releases
Propanc Biopharma Unveils PRP: A Game-Changing Proenzyme Therapy Poised to Challenge Standard Cancer Treatments in the $3+ Billion Pancreatic Cancer Market
February 5, 2026
·
5 min read
Press Releases
Propanc Biopharma Accelerates IP Momentum: Files Fourth Provisional Patent Application in Just Two Months – Strengthening Global Protection for Breakthrough Proenzyme Formulations
January 28, 2026
·
4 min read
Press Releases
Propanc Biopharma Publishes Impact of Proenzymes on Pancreatic Ductal Adenocarcinoma Fibroblasts in Peer Reviewed Journal
December 23, 2025
·
4 min read
Press Releases
Propanc Biopharma Requests Foreign Filing License from Spain for Methods of Treating Resistant Cancer and Fibrosis
December 2, 2025
·
4 min read
Press Releases
Propanc Biopharma Provides Corporate Update and Reports First Quarter 2025/26 Results
November 18, 2025
·
7 min read
Press Releases
Propanc Biopharma Provides Shareholder Update
August 25, 2025
·
7 min read
Press Releases
Propanc Biopharma Announces Closing of Public Offering and Uplisting to NASDAQ
August 20, 2025
·
3 min read
Press Releases
Propanc Biopharma Receives Certificate of Grant for “Proenzyme Composition” Patent from US Patent & Trademark Office
September 18, 2025
·
4 min read
1 of 14
Next
